Hove K, Horst R L, Littledike E T
J Dairy Sci. 1983 Jan;66(1):59-66. doi: 10.3168/jds.S0022-0302(83)81753-6.
Six mature, nonlactating, nonpregnant Jersey cows were treated with five 1-alpha-hydroxylated metabolites of vitamin D3 to compare relative potencies of the metabolites. Blood plasma 1,25-dihydroxyvitamin D peaked at about 1000 pg/ml 12 h after intramuscular injection of 500 micrograms 1,25-dihydroxyvitamin D3 but returned to preinjection concentration within 3 to 4 days. Administration of 500 micrograms 1-alpha-hydroxyvitamin D3 intramuscularly led to a gradual increase in 1,25-dihydroxyvitamin D concentration to 500 pg/ml 48 h after treatment. When 500 micrograms of 1,25-dihydroxyvitamin D3 or 1 alpha-hydroxyvitamin D3 were given orally, plasma 1,25-dihydroxyvitamin D peaked at about 200 and 100 pg/ml, respectively. The decline from peak concentrations occurred more slowly after oral treatment than after intramuscular treatment. Plasma calcium was increased by 20 to 30% for a week or more, depending on 1,25-dihydroxyvitamin D concentrations in plasma. All treatments resulted in calciuria. Treatment with 1 or 3 mg doses of 1,24(R),25-trihydroxyvitamin D3 or both carbon-25 stereoisomers of 1,25,26-trihydroxyvitamin D3 induced smaller and less protracted changes in plasma minerals.
选用6头成熟、非泌乳、未怀孕的泽西奶牛,用维生素D3的5种1-α-羟基化代谢物进行处理,以比较这些代谢物的相对效力。肌肉注射500微克1,25-二羟基维生素D3后12小时,血浆1,25-二羟基维生素D达到峰值,约为1000皮克/毫升,但在3至4天内恢复到注射前浓度。肌肉注射500微克1-α-羟基维生素D3导致1,25-二羟基维生素D浓度在处理后48小时逐渐增加至500皮克/毫升。口服500微克1,25-二羟基维生素D3或1-α-羟基维生素D3时,血浆1,25-二羟基维生素D峰值分别约为200和100皮克/毫升。口服处理后从峰值浓度下降的速度比肌肉注射处理后慢。血浆钙增加20%至30%,持续一周或更长时间,这取决于血浆中1,25-二羟基维生素D的浓度。所有处理均导致尿钙增加。用1毫克或3毫克剂量的1,24(R),25-三羟基维生素D3或1,25,26-三羟基维生素D3的两种碳-25立体异构体进行处理,引起血浆矿物质的变化较小且持续时间较短。